Update on clinical trials for FSHD
Oct 01, 2022•1 hr 14 min•Season 1Ep. 53
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
"Oh, you should never, never, doubt what nobody is sure about." Fulcrum has the losmapimod phase III trial going and now both Roche and Avidity just announced their upcoming clinical trials for FSHD.
For the best experience, listen in Metacast app for iOS or Android